Boston Hospital
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Vection Technologies (ASX:VR1) has seen its shares drop -3.45% in early lunchtime trades despite launching a Massachusetts General Hospital-based AI trial.

That AI product relates to the ‘Digital Box’ suite Vection picked up in late August via its acquisition of privately held Algho AI (one day before its annual report.)

The key offering of the Digital Box product is ‘digital humans’ – in other words, realistic AI-powered chatbots that coincide with a generated representation of a human speaker who doesn’t actually exist.

In short, Digital Box is a sales conversion tool, though it could also help large hospitals handle high-volume numbers of patients by saving human staff from first-appearance interactions.

The company has had its eyes on the healthcare sector since the buy in August, with a presentation at the time pointing to the desire for AI avatars in healthcare, citing a future example of a digital human pharmacy worker.

It was enough to interest Massachusetts General Hospital in Boston, which Vection described as one of America’s best. The Digital Box is now part of a “full-scale trial” with a pilot contract “enhanced by a per-conversation pricing model.”

The tech is being used in paediatric cardiology – perhaps not where parents want to talk to an AI-generated person – but Vection says its tech could facilitate 10,000 visits per year.

Of course, in the often underwhelming and more-troubled-than-advertised world of generative AI ‘chatbots,’ there’s a lot that could go wrong.

Regardless, management was bullish on Tuesday.

“This partnership highlights the transformative potential of AI-powered tools like Katherine in delivering early interventions, improving patient outcomes, and creating efficiencies across healthcare ecosystems,” Vection MD Gianmarco Biagi said.

“This agreement also demonstrates our ability to secure strategic agreements and partnerships in the U.S… We proudly support the hospital’s mission to advance patient care.”

VR1 last traded at 2.8cps.

Join the discussion: See what HotCopper users are saying about Vection and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment adviceViewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

VR1 by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Aussie market weakens on disappointing bank earnings | Feb 19, 2025

The Aussie bourse did not have a great day on Wednesday, falling 0.83% after a selloff…

Hot Chili promises ‘a very large-scale porphyry is emerging’ in RIU Explorer’s address

Hot Chili Ltd continues to build on its shallow and high-grade porphyry discovery, La Verde, in…
Gareth Solley speaking at the RIU Explorer's Conference in WA

RIU Explorers Conference: From Black Cat’s first gold pour to a 200,000 ounce goal

WA Gold producer Black Cat Syndicate (ASX:BC8) has set the goal of producinig 200,000 ounces within…
The Market Online Video

ASX Market Update: Banking sector has another bad day as market pulls back from flat start | Feb 19, 2025

The Australian stock market weakened after a flattish start to Wednesday, with Finance again in the…